Willow Lane Acquisition Corp.

# Signal Note: Driehaus Capital / Willow Lane Acquisition Corp. Driehaus Capital's $4.0M entry into WLACW (warrant position) signals conviction in an upcoming SPAC merger target, likely in the growth-stage biotech space given the fund's portfolio focus. Without the merger announcement yet public, this represents a pre-deal positioning bet; investors should monitor for target disclosure in coming weeks, which typically triggers warrant appreciation if the underlying asset has clinical/commercial catalysts within 12-24 months.